Contribution pulmonaire à l’élimination systémique du propofol chez le patient sous anesthésie générale

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-10-21

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Propofol versus thiopental sodium for the treatment of refractory status epilepticus.

  2015cited by this paper
• Principles of Pharmacology

  2011cited by this paper
• Is propofol an analgesic?

  2011cited by this paper
• The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties

  2008cited by this paper
• CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

  2008cited by this paper
• On-line Monitoring of End-tidal Propofol Concentration in Anesthetized Patients

  2007cited by this paper
• Real-time Monitoring of Propofol in Expired Air in Humans Undergoing Total Intravenous Anesthesia

  2007cited by this paper
• Do the lungs contribute to propofol elimination in patients during orthotopic liver transplantation without veno-venous bypass?

  2006cited by this paper
• Human kidneys play an important role in the elimination of propofol

  2006cited by this paper
• Discontinuous Monitoring of Propofol Concentrations in Expired Alveolar Gas and in Arterial and Venous Plasma during Artificial Ventilation

  2006cited by this paper
• Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.

  2005cited by this paper
• Emerging molecular mechanisms of general anesthetic action.

  2005cited by this paper
• Applications cliniques de la pharmacologie des agents anesthésiques intraveineux (hypnotiques et morphiniques)

  2004cited by this paper
• Propofol: a review of its use in intensive care sedation of adults.

  2003cited by this paper
• Drug handling by the lungs.

  2003cited by this paper
• Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: a feasibility study.

  2003cited by this paper
• Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review

  2002cited by this paper
• Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.

  2002cited by this paper
• Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences

  2000cited by this paper
• Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery.

  2000cited by this paper
• The Combined Effect of Age and Premedication on the Propofol Requirements for Induction by Target-Controlled Infusion

  2000cited by this paper
• Detection of new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry techniques.

  2000cited by this paper
• The Role of Human Lungs in the Biotransformation of Propofol

  2000cited by this paper
• Total intravenous or balanced anaesthesia in ambulatory surgery?

  2000cited by this paper
• Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.

  1999cited by this paper
• Patient-maintained propofol sedation as premedication in day-case surgery: assessment of a target-controlled system.

  1999cited by this paper
• Propofol-infusion syndrome in children.

  1999cited by this paper
• Halothane presynaptically depresses synaptic transmission in wild-type Drosophila larvae but not in halothane-resistant (har) mutants.

  1999cited by this paper
• Propofol: application in veterinary sedation and anesthesia.

  1999cited by this paper
• Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol.

  1998cited by this paper
• [Anesthetics in surgery].

  1998cited by this paper
• The Effects of Propofol on Cerebral Blood Flow Velocity and Cerebral Oxygen Extraction During Cardiopulmonary Bypass

  1998cited by this paper
• Pulmonary Disposition of Propofol in Surgical Patients

  1998cited by this paper
• Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation.

  1997cited by this paper
• The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam.

  1997cited by this paper
• Propofol: pro- or anticonvulsant?

  1997cited by this paper
• Dose of propofol for laryngeal mask airway insertion in children: effect of premedication with midazolam.

  1996cited by this paper
• Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney

  1996cited by this paper
• Why was the urine green?

  1995cited by this paper
• [Characterization of propofol binding to plasma proteins and possible interactions].

  1994cited by this paper
• Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient.

  1994cited by this paper
• [Use of Diprivan for prehospital emergencies].

  1994cited by this paper
• [Use of Diprivan in muscular diseases and malignant hyperthermia].

  1994cited by this paper
• Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.

  1993cited by this paper
• Propofol metabolism in man during the anhepatic and reperfusion phases of liver transplantation.

  1992cited by this paper
• EFFECT OF HALOTHANE ON PULMONARY UPTAKE OF PROPOFOL IN VIVO IN CATS

  1992cited by this paper
• Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC.

  1992cited by this paper
• Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation.

  1992cited by this paper
• Pharmacodynamics of propofol in female patients.

  1992cited by this paper
• Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.

  1992cited by this paper
• The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones

  1991cited by this paper
• Effect of thiopentone, etomidate and propofol on systemic vascular resistance during cardiopulmonary bypass.

  1991cited by this paper
• Species differences in blood profiles, metabolism and excretion of 14C-propofol after intravenous dosing to rat, dog and rabbit.

  1991cited by this paper
• Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil.

  1991cited by this paper
• Randomized comparison of recovery after propofol‐nitrous oxide versus thiopentone‐isoflurane‐nitrous oxide anaesthesia in patients undergoing ambulatory surgery

  1990cited by this paper
• Pharmacokinetics of propofol when given by intravenous infusion.

  1990cited by this paper
• Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery.

  1990cited by this paper
• PHARMACOKINETICS OF PROPOFOL INFUSIONS IN PATIENTS WITH CIRRHOSIS

  1990cited by this paper
• Propofol: assay and regional mass balance in the sheep.

  1989cited by this paper
• Intravenous propofol during cesarean section: placental transfer, concentrations in breast milk, and neonatal effects. A preliminary study.

  1989cited by this paper
• Pharmacokinetic Implications for the Clinical Use of Propofol

  1989cited by this paper
• Effect of diluting propofol on the incidence of pain on injection and venous sequelae.

  1989cited by this paper
• Haemodynamic changes during anaesthesia induced and maintained with propofol.

  1988cited by this paper
• Effects of the anaesthetic 2,6‐diisopropylphenol on synaptic transmission in the rat olfactory cortex slice

  1988cited by this paper
• Pharmacokinetics of propofol (diprivan) in elderly patients.

  1988cited by this paper
• Aetiology of malignant hyperthermia.

  1988cited by this paper
• Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.

  1988cited by this paper
• The effects of cardiopulmonary bypass on plasma concentrations and protein binding of methohexital and thiopental.

  1988cited by this paper
• Comparison of propofol and thiamylal for induction and maintenance of anaesthesia for outpatient surgery.

  1988cited by this paper
• Pharmacokinetics of propofol administered by continuous infusion in patients with cirrhosis

  1988cited by this paper
• Effect of propofol on cerebral blood flow and metabolism in man

  1988cited by this paper
• LUNG CONTRIBUTION TO PROPOFOL CLEARANCEA STUDY IN ISOLATED RAT LUNGS

  1988cited by this paper
• Propofol

  1988influential reference
• [Use of a continuous infusion of propofol in maintaining anesthesia].

  1987cited by this paper
• First Pass Uptake of Fentanyl, Meperidine, and Morphine in the Human Lung

  1987cited by this paper
• Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans

  1987cited by this paper
• Pharmacokinetics of propofol in female patients. Studies using single bolus injections.

  1987cited by this paper
• [Respiratory effects of propofol].

  1987cited by this paper
• Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine.

  1987cited by this paper
• A comparison of the induction characteristics of thiopentone and propofol (2,6-di-isopropyl phenol).

  1986cited by this paper
• Disposition of propofol in patients undergoing surgery. A comparison in men and women.

  1986cited by this paper
• Comparison of induction characteristics of four intravenous anaesthetic agents

  1986cited by this paper
• Pain on i.v. Injection of Propofol (ICI 35 868) in Emulsion Formulation

  1985cited by this paper
• A review of the safety and tolerance of propofol ('Diprivan').

  1985cited by this paper
• Changes in liver function tests after propofol ('Diprivan').

  1985cited by this paper
• The induction of anaesthesia with propofol ('Diprivan') compared in normal and renal failure patients.

  1985cited by this paper
• Propofol ('Diprivan') for outpatient cystoscopy. Efficacy and recovery compared with althesin and methohexitone.

  1985cited by this paper
• Dose response studies with propofol ('Diprivan') in unpremedicated patients.

  1985cited by this paper
• Propofol ('Diprivan') pharmacokinetics and metabolism--an overview.

  1985cited by this paper
• Comparison of methohexitone and propofol ('Diprivan') for induction of enflurane anaesthesia in outpatients.

  1985cited by this paper
• In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol.

  1984cited by this paper
• Pharmacology of an emulsion formulation of ICI 35 868.

  1984cited by this paper
• Pharmacokinetic evaluation of ICI 35 868 in man. Single induction doses with different rates of injection.

  1983cited by this paper
• Dose requirements of ICI 35,868 (Propofol, ‘Diprivan’) in a new formulation for induction of anaesthesia

  1983cited by this paper
• Influence of sample site on blood concentrations of ICI 35868.

  1983cited by this paper
• Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity.

  1982cited by this paper
• Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.

  1980cited by this paper
• Animal studies of the anaesthetic activity of ICI 35 868.

  1980cited by this paper
• The availability of inorganic sulphate as a rate limiting factor in the sulphate conjugation of xenobiotics in the rat? Sulphation and glucuronidation of phenol.

  1979cited by this paper
• DRUG KINETICS AND HEPATIC BLOOD FLOW

  1979cited by this paper

• No citing papers are available for this paper.